九安醫療(002432.SZ):紐約州訂單及合同、馬薩諸塞州訂單均履行完畢
格隆匯4月24日丨 九安醫療(002432.SZ)公佈,近日,經紐約州合同及訂單的兩個採購主體即美國紐約州衞生部和紐約州非盈利組織Health Research Incorporated對賬發現,其對iHealth試劑盒的採購存在訂單未執行完畢的情況。美國當地時間2022年4月22日,美國紐約州衞生部與公司美國子公司溝通上述情況,經雙方協商一致,紐約州訂單及合同採購金額調整為175,225,000美元(含運費),約合人民幣11.32億元(按照2022年4月22日美元兑人民幣匯率中間價1美元=6.4596元人民幣計算)。截至目前,公司已完成了上述紐約州訂單及合同的發貨義務,並收到美國紐約州衞生部支付的全部貨款,上述訂單及合同履行完畢。
截至美國時間2022年4月22日,公司已完成了上述馬薩諸塞州訂單的發貨義務,並收到美國馬薩諸塞聯邦支付的149,333,400美元貨款(實際發生的運費上漲),約合人民幣9.65億元(按照2022年4月22日美元兑人民幣匯率中間價1美元=6.4596元人民幣計算),上述訂單履行完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.